DNA microarrays in lymphoid malignancies

ONCOLOGY

Volumn 17, Issue 12, 2003, Pages 1743-1748

  Rosenwald, Andreas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CLASSIFICATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; LYMPHOMA; MANTLE CELL LYMPHOMA; REVIEW;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 2442565550     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Jaffe ES, Harris NL, Stein H, et al: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001.
2. Campo E, Raffeld M, Jaffe ES: Mantle- cell lymphoma. Semin Hematol 36:115-127, 1999.
3. Swerdlow SH, Williams ME: From centrocytic to mantle cell lymphoma: A clini- copathologic and molecular review of three decades. Hum Pathol 33:7-20, 2002.
4. Schulze A, Downward J: Navigating gene expression using microarrays-a technology review. Nat Cell Biol 3:E190-195, 2001.
5. Coiffier B: Diffuse large cell lymphoma. Curr Opin Oncol 13:325-334, 2001.
6. Fisher RI: Diffuse large-cell lymphoma. Ann Oncol 11 (suppl 1):29-33, 2000.
7. Harris NL, Jaffe ES, Diebold J, et al: Lymphoma classification-from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 11(suppl 1):3-10, 2000.
8. Shipp MA, Ross KN, Tamayo P, et al: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68-74, 2002.
9. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947, 2002.
10. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000.
11. Lossos IS, Alizadeh AA, Eisen MB, et al: Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA 97:10209-10213, 2000.
12. Huang JZ, Sanger WG, Greiner-TC, et al: The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99:2285-2290, 2002.
13. Rosenwald A, Alizadeh AA, Widhopf G, et al: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639-1647, 2001.
14. Davis RE, Brown KD, Siebenlist U, et al: Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194:1861-1874, 2001.
15. Shaffer AL, Rosenwald A, Hurt EM, et al: Signatures of the immune response. Immunity 15:375-385, 2001.
16. Rosenwald A, Wright G, Wiestner A, et al: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185-197, 2003.
17. Hamblin T: Chronic lymphocytic leukaemia: One disease or two? Ann Hematol 81:299-303, 2002.
18. Rai KR, Sawitsky A, Cronkite EP, et al: Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234, 1975.
19. Binet JL, Auquier A, Dighiero G, et al: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981.
20. Damle RN, Wasil T, Fais F, et al: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847, 1999.
21. Hamblin TJ, Davis Z, Gardiner A, et al: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854, 1999.
22. Rajewsky K: Clonal selection and learning in the antibody system. Nature 381:751-758, 1996.
23. Krober A, Seiler T, Benner A, et al: V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410-1416, 2002.
24. Klein U, Tu Y, Stolovitzky GA, et al: Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194:1625-1638, 2001.
25. Wiestner A, Rosenwald A, Barry TS, et al: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944-4951, 2003.
26. Crespo M, Bosch F, Villamor N, et al: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764-1775, 2003.